Albendazole
- Product NDC
- 72205-051
- 11-digit product format
- 722050051
- Labeler code
- 72205
- Product ID
- 72205-051_594f7aab-b336-4d6d-b702-a33346c69645
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Albendazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novadoz Pharmaceuticals LLC
- Application
- ANDA213435
- Marketing category
- ANDA
- Marketing start
- 2021-02-24
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Albendazole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALBENDAZOLE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F4216019LN |
| Rxcui | 199672 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72205-051-08 | Albendazole | 2 in 1 BOTTLE | TABLET | 2 | | 1 |
| 72205-051-28 | Albendazole | 28 in 1 BOTTLE | TABLET | 28 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72205-051 | ALBENDAZOLE TABLET [NOVADOZ PHARMACEUTICALS LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20210226_594f7aab-b336-4d6d-b702-a33346c69645.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72205-051-08 | 72205005108 | 2 TABLET in 1 BOTTLE (72205-051-08) | 2 tablet | 2021-02-24 | 0000-00-00 | No | No | Current |
| 72205-051-28 | 72205005128 | 28 TABLET in 1 BOTTLE (72205-051-28) | 28 tablet | 2021-02-24 | 0000-00-00 | No | No | Current |